Crossmark

Curcumin and/or omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance and blood lipids in individuals with high risk of type 2 diabetes: a randomised controlled trial

Crossref DOI link: https://doi.org/10.1186/s12944-019-0967-x

Published Online: 2019-01-26

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Thota, Rohith N.

Acharya, Shamasunder H.

Garg, Manohar L. http://orcid.org/0000-0003-0514-0865
License Information

Text and Data Mining valid from 2019-01-26
More Information

Article History

Received: 5 December 2018

Accepted: 8 January 2019

First Online: 26 January 2019

Ethics approval and consent to participate

: This study was approved by the University of Newcastle and the Hunter New England Area Health Service Human Research Ethics Committees. The trial has been registered with Australia New Zealand Clinical Trial Registry (ACTRN12615000559516). Informed consent was obtained from all the participants.

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below